. Transforming growth factor-␤ inhibition of proteasomal activity: a potential mechanism of growth arrest.
genic products, tumor suppressors, and enzymes. The essential role of the proteasome in intracellular protein degradation and the necessity for controlled degradation of cell cycle regulatory molecules place the proteasome at the center of cell growth control. Thus modulation of proteasomal activity represents a potential mechanism for the regulation of cell cycle activity.
Transforming growth factor (TGF)-␤ is a potent inhibitor of cell growth and is a member of a superfamily of dimeric polypeptide growth factors that are distinguished from most other cytokines by their ability to limit cell growth (17, 26) . TGF-␤ has diverse effects in addition to regulation of cell growth and participates in morphogenesis and differentiation (18) . The varied cellular functions of this pleiotropic cytokine underlie its critical role in pathophysiological processes such as carcinogenesis. TGF-␤ receptor molecules are expressed ubiquitously, and growth inhibition has been shown to occur in a broad range of epithelial, endothelial, and hematopoietic cells (19) .
TGF-␤ inhibits cell division by triggering a program of cyclin-dependent kinase (cdk) inhibitory responses that culminate in G 1 cell cycle arrest. In epithelial cells from the skin, lung, and breast, TGF-␤ rapidly elevates expression of p15 INK4B (34) . p15 INK4B binds to and inhibits cdk4 and cdk6 as well as displacing the p27 KIP1 protein from these complexes (30, 43) . In proliferating cells, p27 KIP1 remains bound to cdk4 and cdk6 complexes, but when mobilized by TGF-␤, p27 KIP1 binds to and inhibits cdk2 (29) . Prevention or inhibition of G 1 cyclin-cdk activation by TGF-␤ inhibits the phosphorylation of the retinoblastoma protein (14) . In addition, E2F activity is also impaired by TGF-␤ (35) . In keratinocytes, colon and ovarian epithelial cells, TGF-␤ additionally elevates the expression of the p27 KIP1 -related inhibitor p21
, and in mammary epithelial cells, it represses the cdk-activating phosphatase cdc25A. Furthermore, in many cell types, TGF-␤ inhibits c-myc expression, which may play a pivotal role in the loss of G 1 cyclins, downregulation of Cdc25A, or induction of the cdk inhibitor p15 INK4B (4) . Thus growth inhibition by TGF-␤ involves altered cellular expression of multiple cell cycle regulatory molecules.
Proteasomal degradation controls the cellular expression of many key cell cycle regulatory molecules including p27 KIP1 , which participates in TGF-␤ growth inhibition (23, 27) . The degradation of a diverse range of proteins is facilitated by the presence of multiple catalytic activities within the proteasome with the capability for the endoproteolytic cleavage of peptide bonds on the carboxyl side of acidic, basic, and hydrophobic residues of proteins (32) . The activities can be differentially regulated with alterations in biological significance. Differential regulation of these activities can occur by changes in proteasomal subunit composition and may have biological significance (1, 11) . To determine the role of dysregulated proteasomal function during cell growth inhibition by TGF-␤, we first characterized the effect of TGF-␤ on various proteasome-associated hydrolytic activities. TGF-␤ specifically inhibited a hydrolytic activity characterized and quantitated by cleavage of the peptide 7-amido-4-methyl-coumarin (AMC) substrate Cbz-Leu-Leu-Leu-AMC (z-LLL-AMC). We next assessed putative cellular mechanisms involved in the modulation of z-LLL-AMC activity by determining the roles of oxidative stress as well as heat shock protein (HSP)90, an endogenous inhibitor of z-LLL-AMC hydrolysis. Finally, to address the physiological relevance of TGF-␤ inhibition of proteasomal activity, we assessed the role of z-LLL-AMC hydrolysis on cell growth and the expression of cell cycle regulators.
EXPERIMENTAL PROCEDURES
Cell lines. The human biliary epithelial H69 and MzChA-1 cell lines were used for our studies. H69 cells were obtained and used as previously described (24) . Mz-ChA-1 cells were kindly provided by Dr. J. G. Fitz (University of Colorado Health Sciences Center, Denver, CO) and were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum. Mz-ChA-1 cells express very low levels of Smad4 mRNA and are resistant to TGF-␤ growth inhibition. The responsiveness of Mz-ChA-1 cells to TGF-␤ can be restored by transfection with Smad4 (44) .
Sedimentation velocity analysis. Mz-ChA-1 cells were grown to 50-100% confluence in 100 ϫ 20-mm plates. The cells were then washed with cold phosphate-buffered saline (PBS) and lysed with 1 ml of a buffer containing 10 mM HEPES, 100 mM KCl, 5 mM MgCl2, and 0.1% Triton X-100 (pH 7.2), transferred to 12 ϫ 75-mm borosilicate tubes, and homogenized by 20 strokes with a Tissue Tearor (Biospec, Bartlesville, OK). The homogenate was centrifuged at 21,000 g for 20 min at 4°C with a Microfuge R centrifuge (Beckman Instruments, Palo Alto, CA). The supernatant was then subjected to sucrose density gradient centrifugation with 5-30% sucrose in 0.02 M HEPES, pH 7.4, containing 0.15 M sodium chloride, 0.05% (wt/vol) Triton X-100, and 0.02% (wt/vol) sodium azide. After centrifugation at 100,000 g for 22 h in a Beckman LS-70M Ultracentrifuge with a SW41Ti rotor (Beckman Instruments), the gradient was separated into 12 fractions of 1 ml each. Protein content was assessed by the Bradford assay, and proteasomal activity was assessed in each fraction at 37°C for 30 min.
Measurement of cytosolic proteasomal activity. Cells were incubated in 10% fetal bovine serum with or without TGF-␤ for 24 h. The cells were then washed with PBS and lysed with 1 ml of a hypotonic buffer containing 25 mM HEPES, 5 mM MgCl2, 1 mM EGTA, and freshly added 0.5 mM PMSF, 2 g/ml pepstatin, and 2 g/ml leupeptin. Cells were then homogenized by 20 strokes with a Tissue Tearor. The homogenate was centrifuged at 21,000 g for 45 min at 4°C with a Microfuge R centrifuge. The protein content in the supernatant cytosolic fraction was measured with the Bradford reagent. Protease activity was assayed by adding 50 l of cytosolic protein (containing 40-75 g protein) to 0.5 ml of buffer containing 25 mM HEPES, pH 7.5, 10 mM dithiothreitol, 0.1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), 0.5 mM PMSF, 2 l/ml aprotinin, and 20 M fluorescent substrate. The substrates used to assay for proteasomal activity were z-LLL-AMC, Suc-LeuLeu-Val-Tyr-AMC (suc-LLVY-AMC), and Cbz-Leu-Leu-Glu-AMC (z-LLE-AMC). After incubation at 37°C for 30 min, fluorescence was measured every 5 min for 30 min with a fluorometer (TD700; Turner Designs, Mountain View, CA) with excitation and emission wavelengths of 360 and 480 nm, respectively. Hydrolysis of all three substrates was linear with time for up to 3 h and directly proportional to the amount of cytosolic extract used. For experiments involving HSP90, 20 M substrate in enzyme buffer was added to 10 g of cytosolic protein in a final volume of 200 l in 96-well plates. Fluorescence was monitored with a CytoFluor 4000 fluorescence plate reader (PerSeptive Biosystems, Foster City, CA) using excitation and emission wavelengths of 360 and 460 nm, respectively. With each experiment, standard curves were generated with AMC and proteasomal activity was expressed as picomoles of AMC per milligram of protein per minute.
Plasmids and transfection. Plasmids for Smad4 were obtained from Dr. A. Roberts (National Cancer Institute, Bethesda, MD). Mz-ChA-1 cells were transiently transfected with a Perfect Lipid transfection kit (Invitrogen, Carlsbad, CA). Cells were seeded in 24-well plates, grown in serumcontaining medium to 40-60% confluence, and then incubated for 4 h in serum-free medium containing plasmid DNA and lipid in a ratio of 6:1. The medium was then replaced with serum-containing medium. Cells were used 24 h after transfection. Cells were cotransfected with cytomegalovirus (CMV)-␤-galactosidase (␤-gal) to normalize for transfection efficiency, and ␤-gal activity was assessed in cell lysates with chlorophenol red-␤-D-galactopyranoside monosodium (CPRG) and measurement of absorbance at 575 nm.
Quantitation of reactive oxygen species generation. Quantitation of intracellular generation of reactive oxygen species was performed with the oxidant-sensitive fluorescent probe dihydroethidium. This membrane-permeant probe is oxidized within the cell to ethidium, resulting in a marked red shift in its fluorescence spectra. Moreover, the oxidized ethidium remains within the cell because it intercalates with DNA. The fluorescence of ethidium bound to DNA can then be used to quantitate the generation of reactive oxygen species in intact cells (42) . H69 cells were incubated in 96-well plates (1,000 cells/well) in the presence of 20 M dihydroethidium in Krebs-Ringers-HEPES buffer for 30 min at 37°C. Fluorescence was quantitated with excitation and emission wavelengths of 530 and 620 nm, respectively, and a fluorescence multiplate reader (CytoFluor 4000).
Immunoblot analysis. Confluent cells in culture were trypsinized and sonicated for 20 s at 4°C (sonic dismembrator; Fisher Scientific, Pittsburgh, PA) in a lysis buffer containing 50 mM Tris base, 2 mM EDTA, 100 mM NaCl, 1% NP-40, and one mini protease inhibitor cocktail tablet in 25 ml. Protein content was determined by the Bradford assay.
Protein samples were separated on 4-12% gradient polyacrylamide gels (Novex, San Diego, CA) under reducing conditions and electroblotted to positively charged 0.45-m nitrocellulose membrane (Millipore, Bedford, CA). The membranes were soaked for 5 min in transfer buffer (13.4 mM Tris, pH 8.3, 20% methanol, 108 mM glycine). Blots were preblocked in 20 mM Tris, 150 mM NaCl, 0.1% Tween 20, 5% nonfat dry milk for 3-4 h or overnight at 4°C. HSP90 or the cdk inhibitors p16
INK4A , p27 KIP1 , and p21 WAF1/CIP1 were detected by incubating the membrane overnight at 4°C with the respective monoclonal mouse anti-human primary antibody, used at a 1:500 dilution. The primary antibodies were diluted in a solution containing 20 mM Tris, 150 mM NaCl, 0.1% Tween 20, and 5% nonfat dry milk. The membrane was washed twice for 10 min with 20 mM Tris, 150 mM NaCl, and 0.1% Tween 20 (TTBS) and then incubated with the secondary antibody, a polyclonal goat anti-mouse immunoglobulinperoxidase conjugate (Zymed, San Francisco, CA) at a 1:1,000 dilution for 60 min at 4°C. The secondary antibody was diluted in TTBS buffer. For all immunoblots, membranes were washed twice for 10 min with TTBS and then visualized with an enhanced chemiluminescence kit (ECL plus; Amersham Life Science, Little Chalfont, UK) following the manufacturer's directions.
Proliferation assay. Cells were seeded into 96-well plates (5-10,000 cells/well), allowed to adhere, and incubated in a final 200-l volume of medium. Cell proliferation was assessed by a commercially available colorimetric cell proliferation assay (CellTiter 96AQueous; Promega, Madison, WI). The proliferation index was calculated as the percentage of cell number in stimulated to control cultures.
Reagents. DMEM media, fetal bovine serum, and Bradford reagent were obtained from Sigma (St. Louis, MO). PBS, CMRL, DMEM12, glutamine, and antibiotic-antimycotic mix were from GIBCO BRL (Grand Island, New York). Plasmid purification kits were obtained from Qiagen (Valencia, CA). Monoclonal mouse anti-human HSP90, p21 WAF1/CIP1 , p27 KIP1 , and p16 INK4A antibodies were obtained from Pharmingen (San Diego, CA). z-LLL-AMC, z-LLE-AMC, suc-LLVY-AMC, AMC, Cbz-Leu-Leu-leucinal (z-LLL-CHO), HSP90, and U-83836E were obtained from Calbiochem-Novabiochem Corp (San Diego, CA). Protease inhibitor cocktail tablets and CPRG were obtained from Roche Molecular Biochemicals (Indianapolis, IN). All other reagents were of analytical grade from the usual commercial sources.
Statistical analysis. Data are expressed as means Ϯ SE from at least three separate experiments performed in triplicate, unless otherwise noted. The differences between groups were analyzed with a double-sided Student's t-test when only two groups were present. For repeated measures between multiple groups, analysis was performed with ANOVA with a post hoc Bonferroni test to correct for multiple comparisons. Statistical significance was considered as P Ͻ 0.05. Statistical analyses were performed with the GB-STAT statistical software program (Dynamic Microsystems, Silver Spring, MD).
RESULTS

TGF-␤ inhibits a specific proteasome-associated hydrolytic activity.
To ascertain the effect of TGF-␤ on proteasomal function, we first asked whether TGF-␤ altered proteasome-associated hydrolysis. A variety of hydrolytic activities have been identified in proteasomes on the basis of cleavage of peptide-AMC substrates and substrate specificity similarity with other known enzymatic activities such as chymotrypsin and trypsin. The fluorogenic substrate suc-LLVY-AMC has reported specificity and is widely used to assay for 26S proteasomal activity. Although this substrate is useful for chymotrypsin-like activity, it may not detect other hydrolytic activities. Thus we assessed the effect of TGF-␤ on the cleavage of this and two other substrates for proteasome-associated hydrolytic activities, z-LLL-AMC and z-LLE-AMC. Sucrose gradient density centrifugation of cytosolic extracts revealed that maximal hydrolysis of these other substrates occurred in fractions coincident with maximal hydrolysis of suc-LLVY-AMC and with a size Ͼ700 kDa, suggesting that the proteasomal complex was the major cellular source of these hydrolytic activities.
We then assessed the effect of TGF-␤ on hydrolysis of these substrates. Biliary epithelial H69 cells were incubated with 10, 1, 0.1, or 0 ng/ml TGF-␤ for 24 h. Substrate hydrolysis was then fluorometrically assessed in cytosolic extracts. Basal activity was 1.12, 8.33, and 14.52 nmol AMC ⅐ mg protein Ϫ1 ⅐ min Ϫ1 for suc-LLVY-AMC, z-LLE-AMC, and z-LLL-AMC hydrolysis respectively. Incubation with TGF-␤ did not significantly alter the hydrolysis of suc-LLVY-AMC, and a modest increase in z-LLE-AMC was noted only at high concentrations of TGF-␤ (Fig. 1, A and B) . Unexpectedly, TGF-␤ markedly decreased z-LLL-AMC hydrolysis in a concentration-and time-dependent manner (Fig. 1, C and D) . Incubation with the proteasome inhibitor lactacystin (10 M) for 24 h decreased z-LLL-AMC hydrolysis under basal conditions to 18.7 Ϯ 9.2% of controls and during incubation with 10 ng/ml TGF-␤ to 8.4 Ϯ 3.2% of controls. The inhibitory effect of TGF-␤ on z-LLL-AMC hydrolysis was completely abolished by preincubation with the protein synthesis inhibitor cycloheximide (100 g/ml) for 1 h, indicating that TGF-␤ inhibition of z-LLL-AMC hydrolysis involves de novo protein synthesis.
Biliary epithelial Mz-ChA-1 cells have defective TGF-␤-mediated intracellular signaling that can be restored by Smad4 (44) . Inhibition of z-LLL-AMC activity was not observed in Mz-ChA-1 cells. However, partial inhibition of z-LLL-AMC hydrolysis was observed in cells transiently transfected with Smad4 (Fig. 2) . In combination, these studies indicate that TGF-␤ transcriptionally and selectively modulates a proteasome-associated hydrolytic activity with a substrate specificity different from that of suc-LLVY-AMC, a classic substrate used to assay proteasomal chymotrypsin-like activity (22) .
TGF-␤ increases cellular oxidative stress. TGF-␤ has been shown to stimulate cellular production of hydrogen peroxide and to induce intracellular oxidative stress in several different cell types (6, 7, 21, 31, 39, 40) . Furthermore, inhibition of z-LLL-AMC activity was described in response to metal-catalyzed oxidative stress (5). Thus we assessed the potential role of alterations in intracellular oxidative stress on proteasomal function. Cellular extracts were incubated with hydrogen peroxide for varying periods of time to increase intracellular oxidative stress (Fig. 3A) . Incubation with hydrogen peroxide decreased z-LLL-AMC hydrolysis in a time-dependent manner. Likewise, we observed an increase in intracellular reactive oxygen intermediate (ROI) formation during incubation with TGF-␤ (Fig.  3B) . Preincubation of cells with the antioxidant U-83836E (100 M) prevented the loss of z-LLL-AMC activity in response to TGF-␤ (Fig. 3C) . This concentration of U-83836E was chosen on the basis of preliminary studies showing effective reduction in ROI and lipid peroxidation and lack of significant cytotoxicity (Ref. 25 and unpublished data). These findings suggest that cellular oxidative stress may lead to inactivation of z-LLL-AMC hydrolytic activity in response to TGF-␤. A potential mechanism of TGF-␤ modulation of proteasomal function may thus involve oxidative inactivation of specific proteasomal subunits mediating the z-LLL-AMC hydrolysis.
Inhibition of proteasomal hydrolysis by HSP90. Intracellular oxidative stress may increase expression of heat shock proteins. HSP90 has been shown to inhibit proteasomal z-LLL-AMC cleavage (41). Thus we tested the possibility that the effects of TGF-␤ may be mediated via an HSP90-dependent mechanism. Hydrolysis of z-LLL-AMC, but not suc-LLVY-AMC, was decreased in cytosolic extracts in the presence of recombinant HSP90 (Fig. 4, A and B) . Furthermore, the inhibitory effect of HSP90 on z-LLL-AMC hydrolysis was inhibited by preincubation with 2 M geldanamycin, an inhibitor of the biological functions of HSP90. These observations confirmed that HSP90 could act as a functional endogenous inhibitor in H69 cells. We next asked whether TGF-␤ alters expression of HSP90. However, no significant alteration in HSP90 protein levels was observed during incubation with TGF-␤ (Fig. 4, C and D) . Furthermore, incubation with geldanamycin did not alter growth inhibition or substrate hydrolysis by TGF-␤ (data not shown). In combination, these findings suggest that although HSP90 may selectively modulate proteasomal LLL-AMC hydrolysis in vitro, the inhibitory effect of TGF-␤ on this activity is mediated by an HSP90-independent mechanism in vivo. 
TGF-␤ increases expression of p27
kip1 and inhibits cell growth. To assess the functional consequence of proteasomal inhibition by TGF-␤, we next determined the effects of TGF-␤ on cell growth and apoptosis.
Consistent with the reported effects of TGF-␤ on a wide variety of epithelial cell types, incubation with TGF-␤ decreased H69 cell proliferation in a concentrationdependent manner (Fig. 5A) . In contrast, incubation with IL-6, a known biliary epithelial cell mitogen, resulted in an increase in proliferation under the same conditions. Although TGF-␤ can induce apoptosis in hepatic epithelia, TGF-␤ did not significantly increase nuclear fragmentation or activation of caspases-3 or -8 in H69 cells over the same range of concentrations (data not shown). Thus growth inhibition by TGF-␤ involves altered cell cycle progression rather than an increase in apoptosis. Proteasomal degradation has been implicated in the modulation of expression of the cdk inhibitors p21 WAF1/CIP1 and p27 KIP1 , both of which have been implicated in cell cycle arrest by TGF-␤. Quantitative immunoblot analysis indicated that incubation with TGF-␤ did not significantly alter the expression of either p16 or p21 WAF1/CIP1 but increased expression of p27 KIP1 (Fig. 5B) . Preincubation with the antioxidant U-83836E decreased the effect of TGF-␤ on p27 expression (Fig. 6, A and B) and on proliferation (Fig. 6C ). TGF-␤ was shown previously to increase p27 KIP1 by altered degradation rather than via transcriptional mechanisms (15) . Thus manipulation of proteasomal degradation can modulate growth inhibition in response to TGF-␤. Furthermore, the direct regulation of proteasomal activity may have functional implications for TGF-␤-mediated cellular processes other than growth inhibition.
Modulation of proteasomal z-LLL-AMC activity by exogenous inhibitors.
The cell-permeant peptide aldehyde z-LLL-CHO, or MG132, has been used widely in studies evaluating proteasomal degradation of a variety of proteins including transcription factors, cell cycle regulatory proteins, and enzymes. This inhibitor has been shown to reversibly inhibit chymotrypsin-like proteasomal activity. As predicted on the basis of their similar structures, z-LLL-CHO also inhibits z-LLL-AMC hydrolysis. In vitro studies performed on cytosolic extracts revealed that z-LLL-CHO potently inhibited z-LLL-AMC hydrolysis with an IC 50 of 24 nM. In contrast, z-LLL-CHO was a weaker inhibitor of suc-LLVY-AMC or z-LLE-AMC hydrolysis (IC 50 of 45 and 78 M, respectively). Incubation of cells with z-LLL-CHO resulted in increased p27 KIP1 protein expression (Fig. 7, A and B) . Moreover, an effect on cellular growth inhibition was also noted (Fig. 7C ). These observations provide additional support for an important role of proteasomal activity in mediating growth arrest in response to TGF-␤.
DISCUSSION
Our studies demonstrate a selective effect of TGF-␤ on a specific proteasome-associated hydrolytic activity characterized by z-LLL-AMC hydrolysis. The relationship of this observation to cell cycle regulation is emphasized by alterations in p27 KIP1 protein expression and growth inhibition resulting from the modulation of proteasomal function. Thus the direct regulation of specific proteasome-associated hydrolytic activity represents a potential mechanism of cell cycle control. The cell cycle is a precisely controlled process regulated by a complex program involving the temporal expression and degradation of regulatory proteins such as the cyclins, cdk, and cdk inhibitors. Proteolytic degradation of many of these regulatory proteins occurs by the proteasomal complex and is crucial to normal cell cycle progression. Thus the proper control of proteasomal activity is extremely critical. Indeed, in yeast, several proteasome mutants exhibit cell cycle arrest (9, 10) . Recent studies identified and defined a sophisticated, evolutionary conserved system involving ubiquitination that targets proteins for degradation by the proteasome. These targeting systems are believed to represent the primary mechanism for the regulation of degradation of key cell cycle regulatory proteins by the proteasome. However, the presence of alternate mechanisms controlling proteasomal degradation is suggested by the ability of the proteasome to degrade proteins such as c-jun and ornithine decarboxylase without their prior marking by ubiquitin (12, 20) . Furthermore, proteasomal activity can be modulated in vitro by multiple diverse stimuli such as fatty acids, SDS, or polylysine. The critical role of degradative mechanisms is further highlighted by the large numbers of genes that are transcriptionally expressed during the cell cycle (36) . Thus the presence of a mechanism for the direct regulation of proteasomal function in cell cycle control is not surprising. Although reported in vitro studies with Xenopus extracts have shown that proteasomal degradation of a peptide substrate remains constant throughout the cell cycle, we are not aware of any previous reports that describe the regulation of specific proteasomal hydrolytic activities (16) .
The signaling pathways and mechanisms responsible for direct regulation of proteasomal function remain unknown. Several different hydrolytic activities have been identified in human proteasomes. The overall structure of the proteasome consists of four stacked rings, with each of the two end rings containing seven ␣-subunits and the two central rings containing seven ␤-subunits. The active sites are formed by the aminoterminal threonine residues of the ␤-subunits, which face a central cavity in this cylindrical particle (22) . Analysis of yeast mutants defective in various hydro- lyzing activities has revealed that hydrolytic activity is associated with the ␤-subunits. The ␣-subunits act as a template for correct ␤-subunit assembly as well as binding regulatory complexes such as PA28 or REG and PA700, which alter proteasomal proteolytic activities. PA28 is a potent activator that differentially increases peptide hydrolysis by the proteasome. The peptidase activity and substrate specificity of the 20S proteasome can be influenced by association with these regulatory complexes. Thus perturbed proteasomal hydrolysis may result from structural or functional alterations in either ␣-or ␤-subunits. Altered expression of the proteasome and associated regulatory proteins has been described in some physiological conditions such as muscle atrophy due to increased rates of global protein degradation (3) . Alterations in the intracellular localization of the proteasome have also been observed in a cell cycle-specific manner (2). Thus potential mechanisms of selective regulation of z-LLL-AMC hydrolysis by TGF-␤ may involve altered expression of proteasomal subunits, regulatory proteins, or altered intracellular distribution of functionally distinct proteasomal complexes.
Multiple studies have demonstrated a relationship between protein oxidation and proteolysis, and the 26S proteasome has been shown to be susceptible to oxidative inactivation (28, 37) . The cellular generation of ROI by TGF-␤ has been shown to involve induction of NADH oxidase in fibroblasts. A plausible mechanism for the involvement of ROI is the inactivation of critical subunits involved in z-LLL-AMC hydrolysis. Alternatively, TGF-␤ may increase the expression of a specific protein inhibitor that selectively affects specific proteasomal components. TGF-␤ can directly alter the expression of the ␤-catalytic proteasome Z subunit (38) . However, decreased expression of proteasomal components has not been observed during oxidative impairment of proteasomal function (13, 28) . Thus additional studies will be required to ascertain whether the Z subunit participates in the selective hydrolysis of z-LLL-AMC or can be oxidatively modified.
There is considerable emerging evidence that implicates the proteasome in antigen processing. Proteasomal inhibitors can block the generation of class I antigenic peptides and their presentation to cytotoxic lymphocytes. Interferon (IFN)-␥ stimulates antigen presentation and has been shown to stimulate the expression of proteasomal regulators PA28 or 11S (REG). IFN-␥ and TNF-␣ also alter the proteasome subunit composition by replacing the X, Y, and Z catalytic ␤-subunits with other subunits, LMP7, LMP2, and LMP10, respectively (1, 11) . These alterations in the ␤-catalytic subunit composition of the proteasome are expected to alter the hydrolytic activities in a manner that would favor generation of class I antigenic peptides. TGF-␤ has profound effects as a regulator of the immune system and as a potent suppressor of immune cell activity. Indeed, TGF-␤ has been implicated in a broad range of pathogenic mechanisms involving primary effects on immune cells (33) . However, the specific gene targets mediating TGF-␤ regulation of immune cell behavior remain poorly understood. We speculate that modulation of proteasomal function may mediate the immunoregulatory effects of TGF-␤. Studies to ascertain the role of TGF-␤ on proteasomal structure and function are warranted to ascertain the potential involvement of the proteasome in immune function regulation by TGF-␤. The proteasome plays a role in numerous intracellular processes other than cell growth regulation, and dysregulated proteasomal function has been implicated in some disease states. Thus identification of the precise mechanisms by which specific proteasomal activity is regulated in physiological or pathophysiological settings should provide new insights into diverse cellular processes.
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